Effects of ebelactone B, a lipase inhibitor, on intestinal fat absorption in the rat.
Y Nonaka, H Ohtaki, E Ohtsuka, T Kocha, T Fukuda, T Takeuchi, T Aoyagi
Index: J. Enzym. Inhib. 10(1) , 57-63, (1996)
Full Text: HTML
Abstract
Ebelactones A and B, natural products from Streptomyces aburaviensis are potent inhibitors of pancreatic lipase. Lipase is the key enzyme required for the absorption of dietary triglycerides (TG). Ebelactone B inhibited, in a dose-dependent manner, the intestinal absorption of fat after fat-feeding in the rat. The most effective inhibition was observed when the inhibitor was administered at 60 min prior to fat-feeding. When ebelactone B (10 mg/kg) was administered, the serum levels of TG (58%) and cholesterol (36%) were decreased. Since ebelactone B effectively inhibitors absorption of dietary fat, if may provide a promising means for prophylaxis or therapeutics of hyperlipidemia and obesity.
Related Compounds
Related Articles:
Structural studies on ebelactone A and B, esterase inhibitors produced by actinomycetes.
1982-11-01
[J. Antibiot. 35 , 1495-1499, (1982)]
Biosynthetic studies of ebelactone A and B by 13C NMR spectrometry.
1982-12-01
[J. Antibiot. 35 , 1670, (1982)]
2011-07-01
[J. Antibiot. 64(7) , 483-7, (2011)]
Acylpeptide hydrolase: inhibitors and some active site residues of the human enzyme.
1992-02-25
[J. Biol. Chem. 267 , 3811-3818, (1992)]
Human acylpeptide hydrolase. Studies on its thiol groups and mechanism of action.
1994-05-27
[J. Biol. Chem. 269(21) , 15076-84, (1994)]